Please ensure Javascript is enabled for purposes of website accessibility Investing in the next wave of innovative medicines - Janus Henderson Investors
Find your local site

Investing in the next wave of innovative medicines

In our latest panel discussion portfolio manager Andy Acker, research analyst Agustin Mohedas, scientist Dr. Stephen Harrison and Akero's CEO Andrew Cheng, detailed the remarkable advances in disease categories that previously had limited treatment options, like NASH, a severe form of nonalcoholic fatty liver disease.

WEBCAST: Investing in the next wave of innovative medicines

Andy Acker, CFA

Andy Acker, CFA

Portfolio Manager


Agustin Mohedas, PhD

Agustin Mohedas, PhD

Portfolio Manager | Research Analyst


Apr 27, 2023
1 minute watch
Andy Acker, CFA

Andy Acker, CFA

Portfolio Manager


Agustin Mohedas, PhD

Agustin Mohedas, PhD

Portfolio Manager | Research Analyst


Apr 27, 2023
1 minute watch